EnLyte is intended to address the increased need for metabolically-active form of folate in the cerebrospinal fluid, plasma, and/or red blood cells in patients with MTHFR (all alleles C677T, A1298C and/or G1793A) and/or macrocytic anemia. EnLyte may be useful in patients at risk of depression due to a deficiency of folate and/or cobalamin. EnLyte may be taken by patients - ages 12 and up, women of childbearing age, and by geriatric patients where compliance is an issue.
Please refer to the Product Information section for full product details.
Learn More About EnLyte
EnLyte contains Safe, All-Natural, Brain-Ready ingredients!
EnLyte showed effectiveness in a randomized, double-blind, placebo-controlled study
EnLyte combines all of the coenzymes, cofactors and omegas needed within the Methylation Cycles to treat the biochemical root cause of depression